Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
81.50    -2.00 (-2.40%)
Bid:
80.00
Ask:
83.00
Spread: 3.00 (3.75%)
Market Cap: £11.82m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Acquisition

6 Feb 2007 07:00

Adventis Group PLC06 February 2007 For release at 07.00 Feb 6th 2007 ADVENTIS GROUP PLC ACQUISITION OF LEAPFROG MEDICAL COMMUNICATIONS LTD Adventis Group plc ( "Adventis" or the "Company", ticker ATG), the specialistmultimedia and marketing group, is pleased to announce that it has acquiredLeapFrog Medical Communications Limited ("LeapFrog"), a leading medicaleducation company, for a total maximum consideration of £2.65 million. The total consideration will be satisfied by the payment of initialconsideration of £1.306 million, payable as to £0.874 million in cash and £0.432million by the issue of 975,169 new ordinary shares in Adventis ("New OrdinaryShares"), and by deferred consideration of £0.72 million payable in tranches of£0.24 million on each of the first, second and third anniversaries of theacquisition. Each deferred consideration tranche will be satisfied as to 60 percent in cash and as to 40 per cent payable in new ordinary shares in Adventis.There is further deferred consideration payable of up to £0.624 million, basedon the achievement of certain profit growth related criteria over the followingthree years to be satisfied annually according to performance as to 50 per centin cash and 50 per cent payable in new ordinary shares in Adventis. LeapFrog, whose clients include, GSK, Pfizer, MSD, Roche and Novartis, wasestablished in 2001. It provides a range of medical education programmes to thehealthcare industry, promotional aids for sales representatives and alsoinitiates PR campaigns aimed at healthcare professionals and consumers forimproving clients' product brand awareness. For the year ended 30 November 2006,LeapFrog reported audited turnover of approximately £1.57 million and pre-taxprofit of approximately £0.39 million. Net assets at that date amounted toapproximately £0.25 million. Tim Schofield and Gail Rowe, LeapFrog's principaldirectors, will remain with the company following the acquisition. The acquisition will create one of the industry's top three pharmaceuticalindustry service providers, becoming part of an enlarged Healthcare servicesdivision embracing Affiniti Advertising, acquired in 2005, and RoundhouseHealthAd, acquired in 2006. The addition of LeapFrog to Affiniti and Roundhouse creates a formidable,award-winning team in the Adventis Healthcare division, with over 50 employeesworking in centralised premises in the Thames Valley. The enlarged Healthcareservices operations, whose other clients include Boehringer Ingelheim, Allergan,Baxter and Merck Serono, will have the capability to provide a complete range ofintegrated marketing services, from medical education, to advertising to newmedia. It will also provide the opportunity for an increased level ofcross-selling and the ability to provide multinational clients with a greaterlocal understanding of target markets service. Application has been made for the admission to AIM of the New Ordinary Shares,which will rank pari passu with the Company's existing issued ordinary shares,and dealings are expected to commence on 9th February 2007. Charles Phillpot, CEO, Adventis Group, said: "We will now be one of the fewcompanies in the industry to offer a full service marketing capability and theability to handle larger and more complex campaigns for clients. We are nowamong the top three players in two of our three chosen market sectors." Tim Schofield and Gail Rowe said: "We see joining forces with the two topcreative agencies in our industry as a unique way of adding value to ourclients. Being able to address their various needs within one group will be atremendous bonus for us all." ENDS Enquiries: Adventis Group Plc Charles Phillpot, CEO 020 7034 4750 Peter Linnell, Finance Director & Company Secretary 020 7034 4795 Adventis Financial PR Chris Steele 020 7034 4759 Peter Binns 020 7034 4760 Editor's Note: Adventis Group plc, provides a complete range of communications services,including corporate identity programmes, advertising campaigns, media andplanning and buying, literature, public relations, packaging, exhibitions,research and planning, interiors signage and digital media. The group employs145 staff in London and the southeast. Adventis has two other divisions focusing on providing a range of services tothe property and financial sectors. Adventis Group was admitted to AIM in 2004,mainly operating as a media and marketing services provider to the propertysector. LeapFrog becomes the group's ninth operating company. www.adventis.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Mar 201812:49 pmRNSHolding(s) in Company
21st Mar 20185:13 pmRNSHolding(s) in Company
19th Mar 20181:13 pmRNSResult of General Meeting, Issue of Equity, TVR
14th Mar 20184:24 pmRNSIssue of Options
2nd Mar 20186:04 pmRNSPosting of Circular
1st Mar 201811:30 amRNSIncreased Investment in Corallian Energy
28th Feb 20185:11 pmRNSResult of the Placing
28th Feb 201811:26 amRNSConditional Accelerated Bookbuild
27th Feb 201812:30 pmRNSCompany Update regarding the P2235 "Wick" Licence
26th Feb 20181:24 pmRNSStatement re Press Comment
12th Feb 20189:49 amRNSIntention to increase Corallian Energy investment
24th Jan 20185:20 pmRNSHolding(s) in Company
16th Jan 201811:16 amRNSUpdate on UK oil and gas assets
4th Dec 20177:00 amRNSInvestment in Danube Petroleum Limited
14th Nov 20177:00 amRNSPresentation at Investor Evening
1st Nov 20177:00 amRNSInvestment in UK oil and gas assets
27th Oct 20174:19 pmRNSHolding in Company
27th Oct 20179:12 amRNSHolding(s) in Company
19th Oct 20175:48 pmRNSBoard appointments and Issue of Options
16th Oct 20175:29 pmRNSHolding(s) in Company
12th Oct 201712:26 pmRNSResult of General Meeting, Issue of Equity, TVR
9th Oct 20177:00 amRNSSenior Management Appointments
2nd Oct 20174:35 pmRNSProposed subscription to raise £1.76 million
25th Sep 20173:37 pmRNSHolding(s) in Company
22nd Sep 20177:00 amRNSNotice of GM
20th Sep 20177:00 amRNSPlacing to raise £3.96m, update on strategy, TVR
19th Sep 20175:16 pmRNSHalf-year Report
14th Sep 20177:00 amRNSStmnt re Share Price Movement
16th Aug 20171:02 pmRNSResult of AGM
21st Jul 20176:02 pmRNSNotice of AGM
26th Jun 20175:44 pmRNSAnnual Report for year ended 31 December 2016
1st Jun 20178:01 amRNSInvestee company update: process metallurgy
30th May 20177:00 amRNSInvestee Company Update
25th May 20177:00 amRNSInvestee Company Update
2nd May 20174:25 pmRNSTotal Voting Rights
19th Apr 20175:45 pmRNSSubscription Completes, PDMR Shareholdings
19th Apr 20177:15 amRNSLithium-tin project investment, capital raising
28th Oct 201611:35 amRNSResult of AGM
4th Oct 20165:06 pmRNSNotice of AGM and change of registered office
29th Sep 20164:04 pmRNSHalf-year Report
2nd Aug 201611:18 amRNSDirector/PDMR Shareholding
30th Jun 20167:00 amRNSAnnual Financial Report
1st Feb 20161:41 pmRNSTotal Voting Rights
15th Jan 20161:32 pmRNSHolding(s) in Company
8th Jan 20165:45 pmRNSPlacing and Total Voting Rights
29th Sep 201512:05 pmRNSHolding(s) in Company
18th Sep 20155:35 pmRNSUnaudited Interim Results
18th Sep 20155:22 pmRNSPlacing, Total Voting Rights
5th Aug 20153:43 pmRNSResult of AGM
30th Jun 20157:00 amRNSAccounts for year ended 31 December 2014

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.